Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

ADP-heptose is a newly identified pathogen-associated molecular pattern of Shigella flexneri.

García-Weber D, Dangeard AS, Cornil J, Thai L, Rytter H, Zamyatina A, Mulard LA, Arrieumerlou C.

EMBO Rep. 2018 Dec;19(12). pii: e46943. doi: 10.15252/embr.201846943. Epub 2018 Nov 19.

PMID:
30455202
2.

Innate Recognition of Intracellular Bacterial Growth Is Driven by the TIFA-Dependent Cytosolic Surveillance Pathway.

Gaudet RG, Guo CX, Molinaro R, Kottwitz H, Rohde JR, Dangeard AS, Arrieumerlou C, Girardin SE, Gray-Owen SD.

Cell Rep. 2017 May 16;19(7):1418-1430. doi: 10.1016/j.celrep.2017.04.063.

3.

ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria.

Milivojevic M, Dangeard AS, Kasper CA, Tschon T, Emmenlauer M, Pique C, Schnupf P, Guignot J, Arrieumerlou C.

PLoS Pathog. 2017 Feb 21;13(2):e1006224. doi: 10.1371/journal.ppat.1006224. eCollection 2017 Feb.

4.

[Cell biology applications for a type III secretion-based protein delivery tool].

Arrieumerlou C.

Med Sci (Paris). 2016 Oct;32(10):797-799. Epub 2016 Oct 19. French. No abstract available.

5.

A bacterial type III secretion-based protein delivery tool for broad applications in cell biology.

Ittig SJ, Schmutz C, Kasper CA, Amstutz M, Schmidt A, Sauteur L, Vigano MA, Low SH, Affolter M, Cornelis GR, Nigg EA, Arrieumerlou C.

J Cell Biol. 2015 Nov 23;211(4):913-31. doi: 10.1083/jcb.201502074.

6.

Simultaneous analysis of large-scale RNAi screens for pathogen entry.

Rämö P, Drewek A, Arrieumerlou C, Beerenwinkel N, Ben-Tekaya H, Cardel B, Casanova A, Conde-Alvarez R, Cossart P, Csúcs G, Eicher S, Emmenlauer M, Greber U, Hardt WD, Helenius A, Kasper C, Kaufmann A, Kreibich S, Kühbacher A, Kunszt P, Low SH, Mercer J, Mudrak D, Muntwiler S, Pelkmans L, Pizarro-Cerdá J, Podvinec M, Pujadas E, Rinn B, Rouilly V, Schmich F, Siebourg-Polster J, Snijder B, Stebler M, Studer G, Szczurek E, Truttmann M, von Mering C, Vonderheit A, Yakimovich A, Bühlmann P, Dehio C.

BMC Genomics. 2014 Dec 22;15:1162. doi: 10.1186/1471-2164-15-1162.

7.

Conformationally constrained lipid A mimetics for exploration of structural basis of TLR4/MD-2 activation by lipopolysaccharide.

Artner D, Oblak A, Ittig S, Garate JA, Horvat S, Arrieumerlou C, Hofinger A, Oostenbrink C, Jerala R, Kosma P, Zamyatina A.

ACS Chem Biol. 2013 Nov 15;8(11):2423-32. doi: 10.1021/cb4003199. Epub 2013 Sep 26.

8.

Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics.

Schmutz C, Ahrné E, Kasper CA, Tschon T, Sorg I, Dreier RF, Schmidt A, Arrieumerlou C.

Mol Cell Proteomics. 2013 Oct;12(10):2952-68. doi: 10.1074/mcp.M113.029918. Epub 2013 Jul 4.

9.

Shigella flexneri type III secreted effector OspF reveals new crosstalks of proinflammatory signaling pathways during bacterial infection.

Reiterer V, Grossniklaus L, Tschon T, Kasper CA, Sorg I, Arrieumerlou C.

Cell Signal. 2011 Jul;23(7):1188-96. doi: 10.1016/j.cellsig.2011.03.006. Epub 2011 Mar 21.

PMID:
21402152
10.

Endocytosis-independent function of clathrin heavy chain in the control of basal NF-κB activation.

Kim ML, Sorg I, Arrieumerlou C.

PLoS One. 2011 Feb 25;6(2):e17158. doi: 10.1371/journal.pone.0017158.

11.

Cell-cell propagation of NF-κB transcription factor and MAP kinase activation amplifies innate immunity against bacterial infection.

Kasper CA, Sorg I, Schmutz C, Tschon T, Wischnewski H, Kim ML, Arrieumerlou C.

Immunity. 2010 Nov 24;33(5):804-16. doi: 10.1016/j.immuni.2010.10.015.

12.

IKKα contributes to canonical NF-κB activation downstream of Nod1-mediated peptidoglycan recognition.

Kim ML, Jeong HG, Kasper CA, Arrieumerlou C.

PLoS One. 2010 Oct 15;5(10):e15371. doi: 10.1371/journal.pone.0015371.

13.

YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa.

Malone JG, Jaeger T, Spangler C, Ritz D, Spang A, Arrieumerlou C, Kaever V, Landmann R, Jenal U.

PLoS Pathog. 2010 Mar 12;6(3):e1000804. doi: 10.1371/journal.ppat.1000804.

14.

Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion.

Dyachok O, Idevall-Hagren O, Sågetorp J, Tian G, Wuttke A, Arrieumerlou C, Akusjärvi G, Gylfe E, Tengholm A.

Cell Metab. 2008 Jul;8(1):26-37. doi: 10.1016/j.cmet.2008.06.003.

15.

PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.

Thedieck K, Polak P, Kim ML, Molle KD, Cohen A, Jenö P, Arrieumerlou C, Hall MN.

PLoS One. 2007 Nov 21;2(11):e1217.

16.

A local coupling model and compass parameter for eukaryotic chemotaxis.

Arrieumerlou C, Meyer T.

Dev Cell. 2005 Feb;8(2):215-27.

17.

T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase.

Magnan A, Di Bartolo V, Mura AM, Boyer C, Richelme M, Lin YL, Roure A, Gillet A, Arrieumerlou C, Acuto O, Malissen B, Malissen M.

J Exp Med. 2001 Aug 20;194(4):491-505.

18.

Rac is involved in early TCR signaling.

Arrieumerlou C, Randriamampita C, Bismuth G, Trautmann A.

J Immunol. 2000 Sep 15;165(6):3182-9.

19.

The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase.

Genot EM, Arrieumerlou C, Ku G, Burgering BM, Weiss A, Kramer IM.

Mol Cell Biol. 2000 Aug;20(15):5469-78.

20.

Involvement of phosphoinositide 3-kinase and Rac in membrane ruffling induced by IL-2 in T cells.

Arrieumerlou C, Donnadieu E, Brennan P, Keryer G, Bismuth G, Cantrell D, Trautmann A.

Eur J Immunol. 1998 Jun;28(6):1877-85.

21.

Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites.

Deterre P, Gelman L, Gary-Gouy H, Arrieumerlou C, Berthelier V, Tixier JM, Ktorza S, Goding J, Schmitt C, Bismuth G.

J Immunol. 1996 Aug 15;157(4):1381-8.

PMID:
8759717

Supplemental Content

Loading ...
Support Center